<DOC>
	<DOCNO>NCT00304213</DOCNO>
	<brief_summary>This randomize controlled trial testosterone replacement therapy hypogonadal men age &gt; 60 year . The goal ass safety efficacy TRT men age &gt; 60 year .</brief_summary>
	<brief_title>Does Testosterone Improve Function Hypogonadal Older Men</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>age 6080 yr serum total testosterone &lt; 300 ng/dL serum bioavailable testosterone &lt; 70 ng/dL unable provide inform consent history prostate breast cancer untreated sleep apnea</criteria>
	<gender>Male</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>hypogonadism</keyword>
	<keyword>testosterone</keyword>
	<keyword>age</keyword>
	<keyword>Total testosterone &lt; 300 ng/dL</keyword>
	<keyword>Bioavailable testosterone &lt; 70 ng/dL</keyword>
</DOC>